EIF4A3 antigen and antibodies might be useful serum markers in pancreatic cancer diagnosis (34), as they are more strongly expressed in most pancreatic cancer tissues than in normal tissues. This evidence concerns the gene EIF4A3 and familial pancreatic carcinoma.